Bibliographic Details
| Title: |
PHARMACOLOGICAL CHARACTERIZATION OF GLPG3667, A SELECTIVE TYK2 INHIBITOR, SUPPORTS DEVELOPMENT IN DERMATOMYOSITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS. |
| Authors: |
Aggarwal, R., Morand, E. F., Blanque, R., Shoji, K., Jans, M., Marsais, F., Furio, L., Colli, M., Lavazais, S., Cottereaux, C., David, C., Houvenaghel, N., Parent, I., Lagoutte, E., Van de Water, A., Perret, L., Alves, S., Amantini, D., Van der Plas, S., Galien, R. |
| Source: |
Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p1251-1252, 2p |
| Database: |
Complementary Index |
